MetaVia (MTVA): Short-Term Debt to Equity Ratio
This daily price chart for MetaVia Inc (MTVA) demonstrates the current 0.02 metric. MetaVia Inc (MTVA) focuses on developing treatments for dementia and memory disorders, which opens opportunities within the anti-aging therapy segment. However, the business faces the threat of primary trial failures and a lack of liquidity. The absence of sales makes rising trial costs the primary scaling factor.
Analytical breakdowns for MetaVia Inc
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company analysis:MTVA, MetaVia
Maintaining a balance between operational risks and capital efficiency is critical for MetaVia Inc (MTVA) as it develops innovative treatments for neurodegenerative diseases. Analyzing the short-term debt-to-equity ratio allows for an assessment of the company's reliance on obligations maturing within one year relative to its equity, determining the issuer's current financial stability and its ability to sustain scientific research without excessive credit pressure.
Analysis of competing companies
Biogen Corp - Short-Term Debt to Capital|Current Liabilities to Capital Neurocrine Corp NBIX|Short-Term Debt to Equity Ratio RGC (Regencell Bioscience)|axsome.com - Short-Term Debt to Capital|Short-Term Debt to Equity ACADIA Pharmaceuticals Inc. (ACAD)|XENE: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity VKTX|SUPN (Supernus Corp) - Current Liabilities to Capital|Short-Term Debt to Equity CPRX|Short-Term Debt to Equity Ratio denalitherapeutics.com|Harmony Biosciences Holdings, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Biohaven Ltd BHVN|Short-Term Debt to Equity Ratio Amylyx (AMLX)|Short-Term Loans to Capital Ratio Trevi Corp TRVI|Praxis Precision Medicines - Short-Term Debt to Capital|anavex.com (AVXL) - Short-Term Debt to Capital|CeriBell (CBLL) - Short-Term Debt to Equity Ratio|Prothena Biosciences (PRTA) - Short-Term Debt to Equity|ALEC: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Annexon Biosciences Inc.|Short-Term Debt to Capital OMER|Short-Term Debt to Capital neurogene.com NGNE|Short-Term Debt to Equity Ratio AC Immune SA|Ratio of Short-Term Indebtedness to Capital Voyager Therapeutics Inc VYGR|Short-Term Debt to Capital NMRA (Neumora Therapeutics Inc)|SCLX: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Tevogen Bio Holdings|Alpha Cognition Inc. (ACOG) - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital CGTX|Short-Term Debt to Equity Ratio IKT|Short-Term Debt to Equity SAVA (Cassava)|Short-Term Debt to Equity Ratio assertiotx.com ASRT|Short-Term Debt to Equity Ratio Coya Therapeutics (COYA)|VTGN - Short-Term Loans to Capital Ratio|OVID - Short-Term Debt to Equity Ratio|ABOS - Short-Term Debt to Equity|CRVO: Short-Term Debt to Capital|ATHE (Alterity Therapeutics Limited) - Short-Term Debt to Capital|Short-Term Debt to Equity Clene Inc (CLNN)|Short-Term Debt to Capital Ratio PepGen Corp|Jupiter Neurosciences - Short-Term Debt to Capital|Current Liabilities to Capital Relmada Therapeutics Inc RLMD|Short-Term Debt to Equity Ratio ANVS (Annovis Bio Corp)|Grace Therapeutics Inc - Short-Term Debt to Capital|Short-Term Debt to Equity Firefly Neuroscience, Inc (AIFF)|KLTO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity NRSN|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Current Liabilities to Capital|Short-Term Debt to Equity NRXS|Short-Term Debt to Equity Ratio Helius Medical Technologies Inc.|Passage Bio, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital bionomics.com.au NEUP|Short-Term Debt to Equity Ratio Minerva Neurosciences, Inc. (NERV)|Short-Term Loans to Capital Ratio Athira Pharma Inc ATHA|Addex Therapeutics, Ltd. - Short-Term Debt to Capital|Alzamend Neuro, Inc. (ALZN) - Short-Term Debt to Capital|cyclerion.com (CYCN) - Short-Term Debt to Equity Ratio|Protagenic Therapeutics, Inc. (PTIX) - Short-Term Debt to Equity|KTTA: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Cortigent Medical|Short-Term Debt to Capital ATXI|Short-Term Debt to Capital BrainStorm Cell Therapeutics Inc. BCLI|Short-Term Debt to Equity Ratio Cara Therapeutics, Inc.|Ratio of Short-Term Indebtedness to Capital chromocell.com CHRO|Short-Term Debt to Capital ELYM (Eliem)|ITCI: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Longboard Pharma|Marinus Pharma (MRNS) - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital NKGN|Short-Term Debt to Equity Ratio NRBO|Short-Term Debt to Equity SAGE (Sage Therapeutics)|Short-Term Debt to Equity Ratio Synaptogenix Inc. SNPX|Short-Term Debt to Equity Ratio Trevena, Inc (TRVN)|VIGL - Short-Term Loans to Capital Ratio|WENA - Short-Term Debt to Equity Ratio|CERE - Short-Term Debt to Equity